George C. Hillman
Keine laufenden Positionen mehr
Profil
George C.
Hillman was the founder of HemaQuest Pharmaceuticals, Inc. founded in 2007, where he held the title of Chief Operating Officer.
Mr. Hillman also founded Viracta Subsidiary, Inc. Mr. Hillman's former jobs include Chief Executive Officer & Treasurer at Pintex Pharmaceuticals, Inc. from 2003 to 2006, Chief Operating Officer at Paratek Pharmaceuticals, Inc. from 1997 to 2003, and Chief Operating Officer at Cohesive Technologies, Inc. from 1991 to 1997.
Mr. Hillman's education includes an MBA from Rutgers State University of New Jersey and an undergraduate degree from Gannon University.
Ehemalige bekannte Positionen von George C. Hillman
| Unternehmen | Position | Ende |
|---|---|---|
Pintex Pharmaceuticals, Inc.
 Pintex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pintex Pharmaceuticals, Inc. used to discover and develop cancer therapeutics. The company used to discover and commercialize new antibiotics focused on drug resistance. Pintex Pharmaceuticals was founded by Walter Gilbert, Kung Ping Lu and Janusz Sowadski in 1999 and was headquartered in Watertown, MA. | Präsident | 01.01.2006 |
Cohesive Technologies, Inc.
 Cohesive Technologies, Inc. Chemicals: Major DiversifiedProcess Industries Cohesive Technologies, Inc. designs, manufactures, and markets liquid chromatography solutions. It serves to the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company was founded in 1991 and is headquartered in Franklin, MA. | Geschäftsführer | 01.01.1997 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Gründer | - |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Geschäftsführer | - |
| Pricewaterhouse & Co. | Corporate Officer/Principal | - |
Ausbildung von George C. Hillman
| Rutgers State University of New Jersey | Masters Business Admin |
| Gannon University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Paratek Pharmaceuticals, Inc. /Old/
Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Health Technology |
Pintex Pharmaceuticals, Inc.
Pintex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pintex Pharmaceuticals, Inc. used to discover and develop cancer therapeutics. The company used to discover and commercialize new antibiotics focused on drug resistance. Pintex Pharmaceuticals was founded by Walter Gilbert, Kung Ping Lu and Janusz Sowadski in 1999 and was headquartered in Watertown, MA. | Health Technology |
| Pricewaterhouse & Co. | Commercial Services |
Cohesive Technologies, Inc.
Cohesive Technologies, Inc. Chemicals: Major DiversifiedProcess Industries Cohesive Technologies, Inc. designs, manufactures, and markets liquid chromatography solutions. It serves to the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company was founded in 1991 and is headquartered in Franklin, MA. | Process Industries |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
